Related Experiment Videos
The ethics of aggregation and hormone replacement therapy
A D Lyerly1, E R Myers, R R Faden
1The Bioethics Institute, Johns Hopkins University, Baltimore, MD 21205, USA. alyerly@jhsph.edu
Health Care Analysis : HCA : Journal of Health Philosophy and Policy
|September 20, 2001
Summary
Individual patient preferences for health states are crucial for healthcare policy. Aggregating quality of life data risks losing vital personal values, highlighting the need for personalized medical decisions.
Area of Science:
- Health Economics
- Medical Ethics
- Women's Health
Background:
- Aggregated quality of life estimates in policy formation may overlook individual values and deeply held beliefs.
- Feminist moral theories emphasize context and particularity, suggesting the need to understand variations in health state preferences.
Purpose of the Study:
- To empirically investigate preferences for health states related to hormone replacement therapy (HRT).
- To assess the moral relevance of individual variability in health state preferences for clinicians and policymakers.
Main Methods:
- Pilot study involving 16 women aged 45-55 undergoing hormone replacement therapy (HRT).
- Quantified preferences (utilities) for five HRT-associated health states: menopausal symptoms, HRT side effects, breast cancer, myocardial infarction, and osteoporosis.
- Utilized visual analog scale (VAS) and standard gamble (SG) methods to assess utility and time preference (discount rate).
Main Results:
- Significant variability in preferences for health states associated with hormone replacement therapy (HRT) was observed.
- Individual responses demonstrated a wide range of utilities and discount rates, underscoring diverse values.
Conclusions:
- Wide variability in patient preferences necessitates tailoring healthcare decisions to individual women.
- Policy guidelines using utility analysis must acknowledge the limitations of aggregated data and the moral significance of individual health conceptions.